Hiroki Masuda

1.4k total citations
58 papers, 994 citations indexed

About

Hiroki Masuda is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Hiroki Masuda has authored 58 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 22 papers in Neurology and 9 papers in Molecular Biology. Recurrent topics in Hiroki Masuda's work include Multiple Sclerosis Research Studies (29 papers), Peripheral Neuropathies and Disorders (15 papers) and Systemic Lupus Erythematosus Research (7 papers). Hiroki Masuda is often cited by papers focused on Multiple Sclerosis Research Studies (29 papers), Peripheral Neuropathies and Disorders (15 papers) and Systemic Lupus Erythematosus Research (7 papers). Hiroki Masuda collaborates with scholars based in Japan, China and Germany. Hiroki Masuda's co-authors include Satoshi Kuwabara, Y Tajima, Y. Sugita, Nobuyuki Okamura, Masahiro Mori, Akiyuki Uzawa, Ryohei Ohtani, Tomohiko Uchida, Mayumi Muto and Atsuhiko Sugiyama and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Neurology.

In The Last Decade

Hiroki Masuda

51 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Masuda Japan 15 344 269 267 240 216 58 994
Xi Shen China 22 45 0.1× 492 1.8× 157 0.6× 123 0.5× 62 0.3× 102 1.5k
Yaping Yan China 17 24 0.1× 339 1.3× 98 0.4× 105 0.4× 55 0.3× 58 750
Trina Johnson Canada 16 459 1.3× 439 1.6× 36 0.1× 22 0.1× 126 0.6× 19 1.2k
Ashwin Dalal India 20 92 0.3× 651 2.4× 15 0.1× 104 0.4× 46 0.2× 151 1.4k
Annie Boucher Canada 17 56 0.2× 334 1.2× 116 0.4× 24 0.1× 64 0.3× 26 870
Alexandra Kaser-Eichberger Austria 19 48 0.1× 590 2.2× 51 0.2× 60 0.3× 45 0.2× 52 1.3k
Nicholas Schwab Germany 29 676 2.0× 439 1.6× 16 0.1× 65 0.3× 285 1.3× 67 2.4k
Alison K. Cross United Kingdom 17 664 1.9× 290 1.1× 7 0.0× 89 0.4× 40 0.2× 30 1.4k
Jacqueline Mikol France 22 91 0.3× 496 1.8× 18 0.1× 36 0.1× 375 1.7× 65 1.4k
Claudia Capurro Argentina 18 68 0.2× 719 2.7× 33 0.1× 52 0.2× 16 0.1× 54 1.2k

Countries citing papers authored by Hiroki Masuda

Since Specialization
Citations

This map shows the geographic impact of Hiroki Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Masuda more than expected).

Fields of papers citing papers by Hiroki Masuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Masuda. The network helps show where Hiroki Masuda may publish in the future.

Co-authorship network of co-authors of Hiroki Masuda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Masuda. A scholar is included among the top collaborators of Hiroki Masuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Masuda. Hiroki Masuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uzawa, Akiyuki, Masahiro Mori, Hiroki Masuda, et al.. (2024). Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients. Journal of Neurology Neurosurgery & Psychiatry. 95(7). 626–629. 4 indexed citations
2.
Uzawa, Akiyuki, Masahiro Mori, Hiroki Masuda, et al.. (2024). Contributions of CSF interleukin-6 elevation to the pathogenesis of myelin oligodendrocyte glycoprotein antibody–associated disease. Multiple Sclerosis Journal. 30(8). 977–982. 4 indexed citations
3.
Asseyer, Susanna, Hiroki Masuda, Masahiro Mori, et al.. (2021). AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(2). 3080370062–3080370062. 6 indexed citations
4.
Masuda, Hiroki, Masahiro Mori, Shigeki Hirano, et al.. (2021). Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. Journal of Neurology Neurosurgery & Psychiatry. 93(1). 32–40. 25 indexed citations
5.
Takemura, Naoki, Masahiro Mori, Yoichi Suzuki, et al.. (2021). Cryptococcal Meningitis in a Fingolimod-Treated Patient. Neurology Clinical Practice. 11(4). e549–e550. 5 indexed citations
6.
Hamanaka, Kohei, Satomi Mitsuhashi, Hiroki Masuda, et al.. (2020). Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology. 94(23). 88 indexed citations
7.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2020). Comparison of brain atrophy in patients with multiple sclerosis treated with first‐ versus second‐generation disease modifying therapy without clinical relapse. European Journal of Neurology. 27(10). 2056–2061. 4 indexed citations
8.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2020). Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis. PLoS ONE. 15(4). e0224419–e0224419. 12 indexed citations
9.
Liu, Jia, Masahiro Mori, Kazuo Sugimoto, et al.. (2019). Peripheral blood helper T cell profiles and their clinical relevance in MOG-IgG-associated and AQP4-IgG-associated disorders and MS. Journal of Neurology Neurosurgery & Psychiatry. 91(2). 132–139. 21 indexed citations
10.
Ohtani, Ryohei, Masahiro Mori, Tomohiko Uchida, et al.. (2018). Risk factors for fingolimod-induced lymphopenia in multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(1). 2453179660–2453179660. 14 indexed citations
11.
Masuda, Hiroki, Shigeki Hirano, Nobuyoshi Takahashi, et al.. (2017). Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PLoS ONE. 12(8). e0184012–e0184012. 13 indexed citations
12.
Uzawa, Akiyuki, Masahiro Mori, Hiroki Masuda, et al.. (2017). Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica. Clinica Chimica Acta. 469. 144–149. 34 indexed citations
13.
Masuda, Hiroki, Masahiro Mori, Tomohiko Uchida, et al.. (2017). Soluble CD40 ligand contributes to blood–brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder. Journal of Neuroimmunology. 305. 102–107. 41 indexed citations
14.
Masuda, Hiroki, Masahiro Mori, Akiyuki Uzawa, et al.. (2016). Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis. Journal of the Neurological Sciences. 367. 375–379. 15 indexed citations
15.
Muto, Mayumi, Masahiro Mori, Takaki Hiwasa, et al.. (2015). Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies. Journal of Neuroimmunology. 284. 30–36. 16 indexed citations
16.
Masuda, Hiroki, et al.. (2014). Steroid-Responsive Epilepsia Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy. Case Reports in Neurology. 6(2). 166–170. 4 indexed citations
17.
Masuda, Saeko, Masahiro Mori, Kimihito Arai, et al.. (2014). Epstein-Barr virus persistence and reactivation in neuromyelitis optica. Journal of Neurology Neurosurgery & Psychiatry. 86(10). 1137–1142. 32 indexed citations
18.
Masuda, Hiroki, Yoshikazu Kobayashi, Akira Toyama, et al.. (2007). Drug Administration Database Effective in Counseling for Pregnant Women. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(1). 70–77. 1 indexed citations
19.
Masuda, Hiroki, et al.. (2003). The Rates of Successfully Finding Appropriate Drug Information about the Teratogenic Risk Categories. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29(2). 196–202. 1 indexed citations
20.
Masuda, Hiroki, et al.. (2002). Preconceptional and Postexposure Counseling. Drugs in Pregnancy.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 28(4). 366–372. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xi Shen Breakdown of academic impact, for papers by Yaping Yan Breakdown of academic impact, for papers by Trina Johnson Breakdown of academic impact, for papers by Ashwin Dalal Breakdown of academic impact, for papers by Annie Boucher Breakdown of academic impact, for papers by Alexandra Kaser-Eichberger Breakdown of academic impact, for papers by Nicholas Schwab Breakdown of academic impact, for papers by Alison K. Cross Breakdown of academic impact, for papers by Jacqueline Mikol Breakdown of academic impact, for papers by Claudia Capurro
Rankless by CCL
2026